Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 19, 2024, titled "Aurobindo Pharma receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray 50 mcg/spray ".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 19, 2024, titled "Aurobindo Pharma receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray 50 mcg/spray ".